OPT can apply for an Overseas Finding in order to claim overseas expenditure under the R&D Tax Incentive. This would be approved if they can prove that part / all of the clinical trials can't be conducted in Australia and can only be conducted OS (e.g. Australia doesn't have a sufficient number of the type of patients they need to test under the trial).
Cash on hand, page-13
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
0.030(4.76%) |
Mkt cap ! $812.5M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 67.5¢ | 62.0¢ | $2.533M | 3.887M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14912 | 66.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 19820 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |